Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 62, Issue 8, 2002, Pages 623-630

  Schousboe, K ^a   Henriksen, J E ^b   Kyvik, K O ^b   Sorensen T I A ^b   Hyltoft Petersen, P ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NONE

Author keywords

HOMA; OGTT; Within subject biological variation

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CALCULATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REPRODUCIBILITY; STATISTICAL ANALYSIS;

ADULT; BLOOD GLUCOSE; CHEMISTRY, CLINICAL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; WORLD HEALTH ORGANIZATION;

ADA;

EID: 0036945793     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655102764654358     Document Type: Article

References (45)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997; 7: 1183-97
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
3. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation 1999; 1-38
4. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995; 44: 1386-91.
5. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988-92.
6. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985: 28: 412-9.
7. Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assessment of insutin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000; 43: 1507-11.
8. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001; 24: 362-5.
9. Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Coron Artery Dis 2001; 12: 413-23.
10. Kumar S, Prange A, Schulze J, Lettis S, Barnett AH. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients. Diabet Med 1998; 15: 772-9.
11. Freeman H, Looney JM, Hoskins RG. "Spontaneous" variability of oral glucose tolerance. J Crin Endocrinol Metab 1942; 2: 431-4.
12. Unger HR. The standard two-hour oral glucose tolerance test in the diagnosis of diabetes mellitus in subjects without fasting hyperglycemia. Ann Intern Med 1957; 47: 1138-53.
13. Baird JD, Duncan LJP. The Glucose Tolerance Test. Postgrad Med 1959; 35: 308-14.
14. Acland JD, Clayton H, Mitchell B. Reproducibility of a glucose tolerance test. J Appl Physiol 1960; 17: 119-22.
15. West KM, Wulff JA, Reigel DG, Fitzgerald DT. Oral carbohydrate tolerance tests. Arch Intern Med 1963; 113: 641-8.
16. McDonald GW, Fisher GF, Burnham C. Reproducibility of the oral glucose tolerance test. Diabetes 1965; 14: 473-9.
17. Kosaka K, Mizuno Y, Kuzuya T. Reproducibility of the oral glucose tolerance test and the rice-meal test in mild diabetics. Diabetes 1966; 15: 901-4.
18. Kahn CB, Soeldner JS, Gleason RE, Rojas L, Camerini-Davalos RA, Marble A. Clinical and chemical diabetes in offspring of diabetic couples. N Engl J Med 1969; 281: 343-7.
19. Sisk CW, Burnham CE, Stewart J, McDonald GW. Comparison of the 50 and 100 gram oral glucose tolerance test. Diabetes 1970; 19: 852-62.
20. Harding PE, Oakley NW, Wynn V. Reproducibility of oral glucose tolerance data in normal and mildly diabetic subjects. Clin Endocrinol (Oxf) 1973; 2: 387-95.
21. Olefsky JM, Reaven GM. Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 1974; 23: 449-53.
22. Feskens EJ, Bowles CH, Kromhout D. Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 1991; 44: 947-53.
23. Cummings ST, Fraser CG. Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests. Ann Clin Biochem 1988; 25: 634-7.
24. Wolever TM, Chiasson JL, Csima A, Hunt JA, Palmason C, Ross SA, Ryan EA. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose. Diabetes Care 1998; 21: 336-40.
25. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996; 39: 298-305.
26. Young DS, Harris EK, Cotlove E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designed to eliminate long-term analytic deviations. Clin Chem 1971; 17: 403-10.
27. Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med 1994; 118: 496-500.
28. Harris EK, Kanofsky P, Shakarji G, Cotlove E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. II. Estimating biological components of variation. Clin Chem 1970; 16: 1022-7.
29. Godsland IF. Intra-individual variation: significant changes in parameters of lipid and carbohydrate metabolism in the individual and intra-individual variation in different test populations. Ann Clin Biochem 1985; 22: 618-24.
30. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001; 86: 5457-64.
31. Banauch D, Brummer W, Ebeling W, Metz H, Rindfrey H, Lang H, Leybold K, Rick W, Staudinger HJ. A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl). Zeits Klin Chem Klin Biochem 1975; 13: 101-107.
32. Hemmila I, Dakubu S, Mukkala VM, Siitari H, Lovgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984; 137: 335-43.
33. Motala AA, Omar MA, Gouws E. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM. Diabetes Care 1997; 20: 1101-7.
34. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 1997; 20: 1562-8.
35. Tanaka Y, Atsumi Y, Asahina T, Hosokawa K, Matsuoka K, Kinoshita J, Onuma T, Kawamori R. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to ah oral glucose load in newly diagnosed Japanese diabetic subjects. Diabetes Care 1998; 21: 1133-7.
36. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
37. Jörgensen LG, Stahl M, Brandslund I, Hyltoft Petersen P, Borch-Johnsen K, de Fine ON. Plasma glucose reference interval in a low-risk population. II. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001; 61: 181-90.
38. von Eyben FE, Petersen PH, Blaabjerg O, Madsen EL. Analytical quality specifications for serum lactate dehydrogenase isoenzyme 1 based on clinical goals. Clin Chem Lab Med 1999; 37: 553-61.
39. Harris EK, Yasaka T. On the calculation of a "reference change" for comparing two consecutive measurements. Clin Chem 1983; 29: 25-30.
40. Costongs GM, Janson PC, Bas BM, Hermans J, van Wersch JW, Brombacher PJ. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem 1985; 23: 7-16.
41. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999; 354: 617-21.
42. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insutin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
43. Dybkaer R, Jörgensen K. Measurement, value, and scale. Scand J Clin Lab Invest 1989; Suppl. 194: 69-76.
44. Wojtaszewski JF, Hansen BF, Gade, Kiens B, Markuns JF, Goodyear LJ, Richter EA. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 2000; 49: 325-331.
45. Medhus AW, Sandstad O, Naslund E, Hellstrom PM, Husebye E. The influence of the migrating motor complex on the postprandial endocrine response. Scand J Gastroenterol 1999; 34: 1012-8.